###begin article-title 0
###xml 19 22 <span type="species:ncbi:10116">rat</span>
Phosphorylation of rat mitochondrial transcription termination factor (mTERF) is required for transcription termination but not for binding to DNA
###end article-title 0
###begin p 1
###xml 239 257 239 257 <email xmlns:xlink="http://www.w3.org/1999/xlink">fazorin@iib.uam.es</email>
To whom correspondence should be addressed at Departamento de Bioquimica (B-19), Facultad de Medicina (CSIC-UAM), Universidad Autonoma de Madrid, Arturo Duperier 4, E-28029 Madrid, Spain. Tel: +34 91 497 5408; Fax: +34 91 585 4401; Email: fazorin@iib.uam.es
###end p 1
###begin p 2
###xml 1223 1230 1223 1230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 506 509 <span type="species:ncbi:10116">rat</span>
###xml 648 653 <span type="species:ncbi:9606">human</span>
###xml 665 668 <span type="species:ncbi:10116">rat</span>
###xml 1080 1085 <span type="species:ncbi:9606">human</span>
Despite the crucial importance of mitochondrial transcription, knowledge of its regulation is poor. Therefore, characterization of mammalian mitochondrial transcription termination factor (mTERF) functionality and regulation is of fundamental biological interest in order to understand the regulation of mitochondrial transcription. Here we report that mTERF is the first protein having a role in mammalian mitochondrial gene expression that appears to be controlled by phosphorylation. Recombinant mature rat mTERF protein has specific DNA-binding capacity for the sequence required for transcrip tion termination. Furthermore, unlike recombinant human mTERF, the rat protein bound to its mitochondrial DNA binding site promotes the termination of transcription initiated with heterologous RNA polymerase. Interestingly, mTERF is a phosphoprotein with four phosphate groups, and while the DNA-binding activity of mTERF is unaffected by the phosphorylation/dephosphorylation state, only the phosphorylated form of the protein is active for termination activity. Moreover, natural human mTERF is also a phosphoprotein and its termination activity is inhibited by dephosphorylation. These data suggest that mTERF functioning in vivo is regulated by phosphorylation.
###end p 2
###begin p 3
DDBJ/EMBL/GenBank accession no. AJ292524
###end p 3
###begin title 4
INTRODUCTION
###end title 4
###begin p 5
###xml 453 454 441 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c1">1</xref>
###xml 757 758 745 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c2">2</xref>
Mitochondria are involved in many essential metabolic pathways, including the production of most of the cellular ATP through oxidative phosphorylation (OXPHOS system). In mammalian cells, each organelle contains several copies of the mitochondrial genome, which is represented as a closed circular DNA of approximately16.6 kb. The mitochondrial DNA (mtDNA) encodes 37 genes: 22 tRNA, 2 rRNA and 13 polypeptides that are components of the OXPHOS system (1). However, most of the subunit components of the aforementioned system, and all the proteins necessary for mitochondrial replication, transcription and translation, are encoded by nuclear genes. These proteins are synthesized by cytoplasmic ribosomes as precursors and then imported into mitochondria (2).
###end p 5
###begin p 6
###xml 148 149 148 149 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H</sub>
###xml 251 253 251 253 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H1</sub>
###xml 259 260 259 260 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 264 266 264 266 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H1</sub>
###xml 314 315 314 315 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 348 349 348 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c3">3</xref>
###xml 406 408 406 408 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H2</sub>
###xml 432 435 432 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Phe</sup>
###xml 489 490 489 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c4">4</xref>
###xml 491 492 491 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c5">5</xref>
###xml 575 577 575 577 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H2</sub>
###xml 767 769 767 769 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H1</sub>
###xml 900 901 900 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c4">4</xref>
###xml 902 903 902 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c6">6</xref>
###xml 1109 1117 1109 1117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Leu(UUR)</sup>
###xml 1125 1126 1125 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c7">7</xref>
###xml 1127 1128 1127 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c8">8</xref>
###xml 1310 1318 1310 1318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Leu(UUR)</sup>
###xml 1403 1404 1403 1404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c8">8</xref>
###xml 1405 1406 1405 1406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c9">9</xref>
###xml 1669 1671 1669 1671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c10">10</xref>
###xml 1420 1425 <span type="species:ncbi:9606">human</span>
Expression of mammalian mtDNA is initiated from a regulatory site in the molecule called the D-loop region that contains an origin of replication (OH) and the transcription promoters. In this mtDNA there are two major transcription initiation sites (IH1 and IL); IH1 is located in the H-strand promoter (HSP) and IL in the L-strand promoter (LSP) (3). A second initiation site for H-strand transcription (IH2) is located in the tRNAPhe gene, immediately adjacent to the gene for 12S rRNA (4,5). According to this dual H-strand transcription model, transcription starting at IH2 is less frequent and results in polycistronic molecules corresponding to almost the entire H-strand, yielding 12 mRNAs and 12 tRNAs. However, transcription starts relatively frequently at IH1 and then terminates at the downstream end of the 16S rRNA gene, directing the synthesis of the 2 rRNAs (16S and 12S) and 2 tRNAs (4-6). The difference, then, in the synthesis rate of rRNA and mRNA, besides being regulated at the level of transcription initiation, is explained by an attenuation event at the border of the 16S rRNA and tRNALeu(UUR) genes (7,8). The factor mediating termination of transcription is the mitochondrial transcription termination factor (mTERF), a DNA-binding protein that protects a 28 bp region within the tRNALeu(UUR) gene at a position immediately adjacent to the downstream end of the 16S rRNA gene (8,9). Cloning of human mTERF has provided evidence for a novel DNA-binding motif, in which three leucine zippers form an intramolecular three-stranded coiled-coil that brings two widely separated basic domains into close register with the mTERF target DNA sequence (10).
###end p 6
###begin p 7
###xml 77 85 77 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 356 364 356 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 21 24 <span type="species:ncbi:10116">rat</span>
###xml 330 333 <span type="species:ncbi:10116">rat</span>
###xml 423 426 <span type="species:ncbi:10116">rat</span>
In the present work, rat mTERF cDNA has been cloned, sequenced and expressed in vitro and in bacteria. The recombinant protein has been imported into isolated mitochondria and processed to the mature form. The mature recombinant protein exhibits the expected specific DNA-binding capacity to the corresponding termination site in rat mtDNA and it promotes in vitro transcription termination. Furthermore, the capability of rat mTERF to terminate transcription is modulated by multiple phosphorylations.
###end p 7
###begin title 8
MATERIALS AND METHODS
###end title 8
###begin title 9
###xml 24 27 <span type="species:ncbi:10116">rat</span>
Cloning and sequence of rat mTERF cDNA
###end title 9
###begin p 10
###xml 35 37 35 37 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c10">10</xref>
###xml 159 160 159 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 22 27 <span type="species:ncbi:9606">human</span>
###xml 142 145 <span type="species:ncbi:10116">rat</span>
Using the sequence of human mTERF (10), primers were designed to perform the RACE protocols, in order to obtain the entire cDNA sequence from rat liver poly(A)+ RNA.
###end p 10
###begin title 11
Plasmid constructs
###end title 11
###begin p 12
###xml 59 67 59 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 374 381 374 381 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GGG CCC</underline>
###xml 417 424 417 424 <underline xmlns:xlink="http://www.w3.org/1999/xlink">CTG CAG</underline>
###xml 936 943 936 943 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GCT AGC</underline>
###xml 1074 1090 1074 1090 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 36 39 <span type="species:ncbi:10116">rat</span>
###xml 187 190 <span type="species:ncbi:10116">rat</span>
###xml 1074 1090 <span type="species:ncbi:562">Escherichia coli</span>
The r-mTERF plasmid used to produce rat mTERF precursor by in vitro translation was constructed by inserting a EcoRI-HindIII fragment that contains the entire open reading frame (ORF) of rat mTERF into the pSPUTK vector (Stratagene). The sequence encoding the mature protein was PCR amplified using primers that produce a substitution of amino acids FSVE(+4) with MGAQ (R1, GGG CCC AAT GTA ACA GTA AAG ACG G-385; R3, CTG CAG CTA CCC ACT TAA TCT CTT C-1352). The PCR fragment vector was digested with ApaI and PstI and ligated to pSPUTK to give the r-mTERFm plasmid. The pLEX-His vector [which contains the sequence that encodes the histidine tag and the polylinker from pBlueBacHis2B vector (Invitrogen)] was used to express the mature protein in bacteria with a 14 amino acid histidine tag (MPRGSHHHHHHGMA) at the N-terminus. The pLEX-His-mTERF plasmid was constructed by PCR amplification of an appropriate fragment using primers R2 (GCT AGC GTG GAA TGT AAC AGT AAA G-381) and R3. The PCR product was digested with NheI and PstI, cloned into pLEX-His and transformed into Escherichia coli GI724 (Invitrogen). The correct nucleotide sequence of all constructs was verified.
###end p 12
###begin p 13
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c11">11</xref>
###xml 372 373 372 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh528f4">4</xref>
###xml 548 550 548 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c12">12</xref>
###xml 618 625 618 625 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GTC GAC</underline>
###xml 690 697 690 697 <underline xmlns:xlink="http://www.w3.org/1999/xlink">ACA TGT</underline>
###xml 798 799 798 799 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 92 95 <span type="species:ncbi:10116">rat</span>
###xml 436 441 <span type="species:ncbi:9606">human</span>
###xml 535 540 <span type="species:ncbi:9606">human</span>
###xml 747 752 <span type="species:ncbi:9606">human</span>
###xml 819 824 <span type="species:ncbi:9606">human</span>
For construction of the pGTER plasmid used in the transcription termination experiment, the rat mtDNA region between nucleotide positions 2542 and 2761 (11) was PCR amplified and cloned into pGEM-Teasy vector (Promega). The mTERF-binding sequence was placed in direct polarity with respect to the SP6 promoter and in reverse polarity with respect to the T7 promoter (Fig. 4A). The pGHLT plasmid was obtained by inserting an AflIII-SalI human mtDNA fragment into pGTER. The chimeric fragment of 171 bp comprising nucleotides 360-520 of human mtDNA (12) was PCR amplified using one primer with an AflIII site (360-A ACA GTC GAC CCT AAC ACC AGC CTA AC) and another with a SalI site (520-G GAG ACA TGT GTG TGT GCT GGG TAG). This fragment contains the human L-strand promoter with the initiation site (IL). In this way, the human L-strand promoter replaced the SP6 promoter of pGTER.
###end p 13
###begin title 14
###xml 14 17 <span type="species:ncbi:10116">rat</span>
Expression of rat mTERF
###end title 14
###begin p 15
###xml 0 20 0 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro expression.</italic>
###xml 221 223 221 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 485 487 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c13">13</xref>
###xml 35 38 <span type="species:ncbi:10116">rat</span>
###xml 49 52 <span type="species:ncbi:10116">rat</span>
###xml 152 158 <span type="species:ncbi:9986">rabbit</span>
In vitro expression. The proteins (rat mTERF and rat mTERFm) were expressed in the TNT-coupled transcription-translation system (Promega), which uses a rabbit reticulocyte lysate, following the manufacturer's protocols. [35S]methionine (1000 Ci/mmol) (Amersham) was used to label proteins and the incorporation of radioactive label and the amount of protein synthesized were calculated. When necessary, the encoding proteins were expressed in an uncoupled way as described previously (13).
###end p 15
###begin p 16
###xml 0 23 0 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In bacteria expression.</italic>
###xml 104 105 104 105 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 177 193 177 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 265 268 265 268 <sub xmlns:xlink="http://www.w3.org/1999/xlink">550</sub>
###xml 460 462 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c14">14</xref>
###xml 627 629 611 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 36 39 <span type="species:ncbi:10116">rat</span>
###xml 177 193 <span type="species:ncbi:562">Escherichia coli</span>
###xml 405 408 <span type="species:ncbi:10116">rat</span>
In bacteria expression. The protein rat his-mTERF (in pLEX vector) was expressed in bacteria using the PL Expression System (Invitrogen) following the manufacturer's protocols. Escherichia coli transformed with pLEX-His-mTERF were grown in induction medium to an OD550 of 0.5 at 30degreesC. The expression was induced at 37degreesC for 4 h by the addition of 100 microg/ml tryptophan. The purification of rat his-mTERF was carried out as described previously (14). Following induction of expression, bacterial pellets were isolated, dissolved in 6 M guanidinium chloride, 20 mM Tris-HCl (pH 7.9) and 500 mM NaCl and bound to Ni2+-loaded HiTrap affinity columns (Pharmacia-Biotech). The columns were washed with 6 M urea, 20 mM Tris-HCl (pH 7.9), 500 mM NaCl and 20 mM imidazole and the urea removed with 20 mM Tris-HCl (pH 7.9) and 150 mM NaCl. The soluble protein (his-mTERF) was eluted from the column with 20 mM Tris-HCl (pH 7.9), 150 mM NaCl and 50 mM EDTA and analyzed by 10% (w/v) SDS-PAGE and Coomassie blue staining. The protein content was determined by comparison with marker proteins using densitometry.
###end p 16
###begin title 17
###xml 24 29 <span type="species:ncbi:9606">human</span>
Purification of natural human mTERF
###end title 17
###begin p 18
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c15">15</xref>
###xml 16 21 <span type="species:ncbi:9606">human</span>
###xml 52 57 <span type="species:ncbi:9606">human</span>
Purification of human mTERF was carried out using a human S-100 mitochondrial lysate (h-mtS100) prepared as previously described (15) from HeLa cells, by sequential chromatography through a heparin-agarose column and an oligodeoxynucleotide affinity column.
###end p 18
###begin title 19
Mitochondrial import/processing assay
###end title 19
###begin p 20
###xml 64 66 64 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c16">16</xref>
###xml 179 180 179 180 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 182 183 182 183 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 211 212 211 212 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 417 425 393 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 446 448 422 424 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 1370 1371 1332 1333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m</italic>
###xml 4 7 <span type="species:ncbi:10116">rat</span>
###xml 381 384 <span type="species:ncbi:10116">rat</span>
The rat liver mitochondrial fraction was isolated as described (16), washed twice in incubation medium (10 mM Tris-HCl, pH 7.4, 25 mM sucrose, 75 mM sorbitol, 100 mM KCl, 10 mM KH2PO4, 0.05 mM EDTA and 5 mM MgCl2), resuspended in the same medium at approximately10 mg/ml and immediately used for the import/processing assays at a final concentration of approximately2.5 mg/ml. The rat mTERF precursor was synthesized in vitro in the presence of [35S]methionine and reticulocyte lysate was then added to 12.5% (v/v) to samples of the mitochondrial suspension. Induction medium (1 mg/ml BSA, 2 mM sodium succinate, 1 mM ATP and 1 mM methionine, included to avoid labeling of newly synthesized proteins) was added to the reaction mixtures and these were then incubated at 37degreesC for 1 h. The mitochondria were washed twice with ice-chilled incubation medium and the final pellets were lysed with 1 vol of twice concentrated gel sample buffer. In some experiments, trypsin was added to the incubation mixture at 50 microg/ml after the import/processing reaction and the samples were incubated at room temperature for 10 min before washing and lysis of the mitochondria. In a control experiment in which, beside trypsin (50 microg/ml), Triton X-100 was added to the reaction mixture to 1% (v/v), the washing of mitochondria was omitted. In other assays, carbonyl cyanide m-chlorophenyl hydrazone (CCCP) was included in the reaction mixture at 1.7 microg/ml and incubated at 37degreesC for 30 min. The mitochondrial lysates were analyzed by SDS-PAGE and the gels were fixed, treated with Amplify (Amersham), dried and exposed.
###end p 20
###begin title 21
DNA binding assays
###end title 21
###begin p 22
###xml 371 373 367 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 554 555 540 541 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 28 31 <span type="species:ncbi:10116">rat</span>
DNA-binding activity to the rat termination site was determined by mobility shift assays using a double-stranded 40mer oligodeoxynucleotide probe (L-strand, GG AAG TTA TTA GGG TGG CAG AGC CAA GTA ATT GCG TAA GA-2686; H-strand, GG TCT TAC GCA ATT ACT TGG CTC TGC CAC CCT AAT AAC TT-2649), which was labeled by filling in the 3'-recessed ends with Klenow enzyme and [alpha-32P]dCTP. Various amounts of protein were incubated at 25degreesC for 15 min in 20 microl of reaction mixture containing 10 nM probe, 25 mM HEPES-KOH (pH 7.8), 50 mM KCl, 12.5 mM MgCl2, 0.05% (v/v) Tween-20, 1 mM dithiothreitol (DTT), 20% (v/v) glycerol, 0.1 microg/microl poly(dI.dC) (added as non-specific competitor DNA) and 0.25 microg/microl BSA. After incubation, the reaction mixtures were loaded on a native 5% (w/v) polyacrylamide gel in Tris-glycine buffer and run at 4degreesC.
###end p 22
###begin title 23
Transcription termination assays
###end title 23
###begin p 24
###xml 291 292 281 282 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 405 407 383 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 575 577 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c15">15</xref>
###xml 213 216 <span type="species:ncbi:10116">rat</span>
###xml 447 452 <span type="species:ncbi:9606">human</span>
###xml 732 735 <span type="species:ncbi:10116">rat</span>
The transcription termination reactions were carried out for 30 min at 30degreesC in a 25 microl volume using 500 fmol (20 nM) appropriate digested plasmid, its corresponding RNA polymerase and various amounts of rat mTERF proteins in transcription buffer (10 mM Tris-HCl, pH 8.0, 10 mM MgCl2, 1 mM DTT, 100 microg/ml BSA, 10% v/v glycerol, 1 mM ATP, 0.1 mM GTP and CTP, 0.01 mM UTP and 10 microCi [alpha-32P]UTP). Termination of transcription by human mitochondrial RNA (mtRNA) polymerase was tested in the presence of 10% (v/v) h-mtS100 of a Tween-20 mitochondrial lysate (15). A transcription reaction using 5 U SP6 or T7 RNA polymerase was carried out in the presence of NcoI- or SalI-digested pGTER plasmid, respectively. When rat mTERFm was used, the controls contained the same amount of a non-programmed reticulocyte lysate.
###end p 24
###begin p 25
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c10">10</xref>
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c15">15</xref>
###xml 278 279 268 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c8">8</xref>
###xml 540 541 526 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c9">9</xref>
###xml 24 29 <span type="species:ncbi:9606">human</span>
###xml 351 356 <span type="species:ncbi:9606">human</span>
In the case of purified human mTERF, transcription termination and S1 protection analysis were performed as described previously (10,15). The transcription reactions were carried out at 30degreesC for 30 min in a 25 microl volume using EcoRI- and HindIII-digested pTER plasmid (8) at 20 microg/ml, 10% (v/v) h-mtS100 lysate and 10 ng purified natural human mTERF in transcription buffer. S1 protection assays were performed using, as specific probe, unlabeled RNA synthesized utilizing BamHI-linearized BSAND plasmid and T3 RNA polymerase (9). Termination activity was calculated as the percentage of terminated transcripts relative to total transcripts, after correction for the different content of uridine.
###end p 25
###begin title 26
Two-dimensional (2D) gel electrophoresis
###end title 26
###begin p 27
Proteins were loaded in an IEF Ready Gel pH 3-10 (Bio-Rad) and subjected to isoelectrofocusing according to the instructions of the manufacturer. After isoelectrofocusing, the lanes were equilibrated for 30 min in 0.123 M Tris-HCl (pH 6.8), 10% (v/v) glycerol, 2% (w/v) SDS and 7 mM DTT before being applied for electrophoresis by 12% (w/v) SDS-PAGE.
###end p 27
###begin title 28
Immunodetection analysis
###end title 28
###begin p 29
The anti-phosphoserine (anti-P-S; Zymed), anti-phosphothreonine (anti-P-T; Sigma) and anti-phosphotyrosine (anti-P-Y; UBI) antibodies were used at 1/200, 1/100 and 1/1000 dilutions, respectively, for immunoblot analyses. Blots were developed using alkaline phosphatase-conjugated secondary antibodies (Sigma) at 1/5000 dilution and nitro blue tetrazolium/5-bromo-4-chloroindol-3-yl phosphate (NBT-BCIP) as substrates.
###end p 29
###begin title 30
Phosphatase treatments
###end title 30
###begin p 31
###xml 21 23 21 23 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c15">15</xref>
###xml 34 36 34 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 422 423 402 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 29 32 <span type="species:ncbi:10116">rat</span>
###xml 101 105 <span type="species:ncbi:9913">calf</span>
###xml 182 185 <span type="species:ncbi:10116">rat</span>
###xml 574 579 <span type="species:ncbi:9606">human</span>
Human mtS100 lysate (15) and rat [35S]mTERFm were dephosphorylated at 37degreesC for 20 min with 5 U calf intestinal alkaline phosphatase (CIAP) and then loaded in IEF gel. Purified rat his-mTERF was incubated at a final concentration of 750 nM with agarose (5 microg/microl) or 5 U agarose-conjugated CIAP (Sigma) at 37degreesC for 20 min. Following incubation, the reaction mixture was centrifuged for 1.5 min at 10 000 g and the supernatant used for mitochondrial transcription termination and DNA-binding assays at a final concentration of 120 nM. When purified natural human mTERF was used, 2.5 ng/microl of protein was incubated at 37degreesC for 20 min with 5 U agarose-conjugated CIAP, centrifuged and then used for transcription termination and S1 protection analysis.
###end p 31
###begin title 32
###xml 50 51 50 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 51 52 51 52 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
Measurement of equilibrium dissociation constant (Kd)
###end title 32
###begin p 33
###xml 313 314 313 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 314 315 314 315 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 465 466 462 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y</italic>
###xml 483 484 480 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 484 485 481 482 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 493 494 490 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y</italic>
A series of binding reactions containing a fixed concentration of labeled termination probe was performed at different concentrations of recombinant proteins. The bound and free oligonucleotides were fractionated by mobility shift assay and the amounts were determined by densitometry. The dissociation constant (Kd) corresponding to the dissociation in the equilibrium DNA + protein <--> DNA-protein was calculated by fitting the values to the following equation: Y = 1 + [protein]/Kd, where Y is the fraction of saturated binding sites ([DNA-protein]/([DNA] + [protein])). The binding isotherms were fitted by computer.
###end p 33
###begin title 34
Isoelectric point (pI)
###end title 34
###begin p 35
###xml 217 218 217 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 221 222 221 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 225 226 225 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 226 227 226 227 <sub xmlns:xlink="http://www.w3.org/1999/xlink">f</sub>
###xml 235 236 235 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 236 237 236 237 <sub xmlns:xlink="http://www.w3.org/1999/xlink">f</sub>
###xml 294 295 294 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 295 296 295 296 <sub xmlns:xlink="http://www.w3.org/1999/xlink">f</sub>
###xml 328 329 328 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 329 330 329 330 <sub xmlns:xlink="http://www.w3.org/1999/xlink">f</sub>
###xml 508 509 500 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 509 510 501 502 <sub xmlns:xlink="http://www.w3.org/1999/xlink">f</sub>
Predicted pIs were obtained using the ProtParam tool provided on the ExPASy Molecular Biology Server (). The pI values of IEF standards (Bio-Rad) were fitted, using a linear regression algorithm, to the equation pI = A + B x Rf, where Rf is defined as the distance of a band relative to pH 10 (Rf = 0) and the position at pH 3 (Rf = 1). The pI values of phosphorylated proteins were estimated for the position of the band with respect to the non-phosphorylated one, using the equation DeltapI = -4.47 x DeltaRf, derived from the aforementioned linear regression. Finally, the theoretical pI values of proteins with various numbers of phosphates were calculated using the algorithm from Scansite ().
###end p 35
###begin title 36
RESULTS
###end title 36
###begin title 37
###xml 23 26 <span type="species:ncbi:10116">rat</span>
Structural features of rat mTERF
###end title 37
###begin p 38
###xml 272 273 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh528f1">1</xref>
###xml 1318 1339 1294 1315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Paracentrotus lividus</italic>
###xml 1396 1398 1372 1374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c17">17</xref>
###xml 1424 1447 1400 1423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila melanogaster</italic>
###xml 1504 1506 1480 1482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c18">18</xref>
###xml 11 14 <span type="species:ncbi:10116">rat</span>
###xml 181 184 <span type="species:ncbi:10116">rat</span>
###xml 251 256 <span type="species:ncbi:9606">human</span>
###xml 733 736 <span type="species:ncbi:10116">rat</span>
###xml 889 892 <span type="species:ncbi:10116">rat</span>
###xml 1007 1012 <span type="species:ncbi:10090">mouse</span>
###xml 1039 1044 <span type="species:ncbi:9606">human</span>
###xml 1072 1075 <span type="species:ncbi:9823">pig</span>
###xml 1156 1161 <span type="species:ncbi:9606">human</span>
###xml 1163 1168 <span type="species:ncbi:10090">mouse</span>
###xml 1170 1173 <span type="species:ncbi:9823">pig</span>
###xml 1178 1181 <span type="species:ncbi:10116">rat</span>
###xml 1258 1261 <span type="species:ncbi:10116">rat</span>
###xml 1318 1339 <span type="species:ncbi:7656">Paracentrotus lividus</span>
###xml 1424 1447 <span type="species:ncbi:7227">Drosophila melanogaster</span>
The ORF of rat mTERF cDNA predicts a 374 amino acid protein with a molecular mass of approximately43 kDa and an estimated isoelectric point (pI) value of 9.45. The structure of the rat mTERF sequence conserves the modular organization observed in the human ortholog (Fig. 1): two separated basic regions (B1 and B2), involved in directly binding the protein to its target sequence, and three leucine zipper motifs (Lz1a/b, Lz2 and Lz3), required to bring the two basic domains into close register with the target DNA sequence. It contains a putative mitochondrial targeting sequence of 37 amino acids, with the potential cleavage site placed between P(-1) and F(+1) according to the 'R(-2) rule'. Based on this assignment the mature rat mTERF should be 337 amino acids long and have a calculated molecular mass of approximately38.3 kDa and a pI of 9.20. The deduced amino acid sequence of rat mTERF reveals 90, 75 and 72% overall sequence identity and 96, 89 and 88% overall sequence similarity to those of mouse (accession no. AC068609), human (accession no. Y09615) and pig (accession no. AC92875) mTERF, respectively. The marked sequence homology among human, mouse, pig and rat cDNA suggests that mTERF is a highly conserved protein in mammals. However, rat mTERF displays only 18 and 15% amino acid identity with Paracentrotus lividus mitochondrial transcription termination factor (mtDBP) (17) and the recently cloned Drosophila melanogaster mitochondrial transcription termination factor (DmTTF) (18), respectively (data not shown). These data indicate that mitochondrial transcription termination factors are not highly conserved between mammals and non-mammals.
###end p 38
###begin p 39
###xml 83 91 83 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 140 141 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh528f2">2</xref>
###xml 301 309 301 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 455 457 455 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 1262 1263 1262 1263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh528f2">2</xref>
###xml 1443 1445 1443 1445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c19">19</xref>
###xml 72 75 <span type="species:ncbi:10116">rat</span>
###xml 315 321 <span type="species:ncbi:9986">rabbit</span>
###xml 364 367 <span type="species:ncbi:10116">rat</span>
###xml 397 400 <span type="species:ncbi:10116">rat</span>
###xml 427 430 <span type="species:ncbi:10116">rat</span>
###xml 567 570 <span type="species:ncbi:10116">rat</span>
###xml 742 745 <span type="species:ncbi:10116">rat</span>
In order to obtain direct evidence of the mitochondrial localization of rat mTERF, in vitro import/processing assays were carried out (Fig. 2A). A construct containing the entire ORF and another having a deletion of the fragment that codifies the putative mitochondrial target sequence were expressed in vitro in a rabbit reticulocyte lysate to give the precursor rat mTERF and the mature protein rat mTERFm, respectively. The rat mTERF was labeled with [35S]methionine and then incubated with isolated mitochondria (lane 1). After incubation in the presence of ATP, rat mTERF yielded a second, shorter band where the mitochondrial leader peptide had been cleaved off (lane 2). This band had the same electrophoretic mobility as observed for rat mTERFm (lane 5). Protein internalization into mitochondria was then assayed by exposure to trypsin. The processed product (mature protein), in contrast to the precursor, was resistant to trypsin treatment (lane 3), but became protease sensitive after solubilization of the membranes with Triton X-100 (lane 4). This result demonstrates that the mature protein was internalized within the inner mitochondrial compartment, which is impermeable to trypsin. Furthermore, import was inhibited by the uncoupler CCCP (Fig. 2A, lane 7), as expected from the requirement for a membrane potential for mitochondrial import. All these properties are characteristic of a typical mitochondrial import reaction (19).
###end p 39
###begin title 40
###xml 23 26 <span type="species:ncbi:10116">rat</span>
Functional analysis of rat mTERF
###end title 40
###begin p 41
###xml 164 172 164 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 273 275 273 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 348 349 348 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh528f2">2</xref>
###xml 750 751 750 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 751 752 751 752 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 67 70 <span type="species:ncbi:10116">rat</span>
###xml 219 222 <span type="species:ncbi:10116">rat</span>
###xml 319 322 <span type="species:ncbi:10116">rat</span>
###xml 624 630 <span type="species:ncbi:9986">rabbit</span>
###xml 692 695 <span type="species:ncbi:10116">rat</span>
###xml 776 779 <span type="species:ncbi:10116">rat</span>
In order to investigate the functional capacity of the recombinant rat mTERF, its DNA-binding properties and its transcription termination-promoting activity in an in vitro system were analyzed. The binding capacity of rat mTERFm was determined by gel shift assays using a 32P-labeled probe that contained the putative rat mTERF binding site (Fig. 2B). The recombinant mature protein was able to bind the probe producing a single retarded band. Increasing the amount of the protein resulted in an increase in the intensity of the retarded band, without the appearance of any more slowly moving secondary band. The amount of rabbit reticulocyte lysate was kept constant even in the absence of rat mTERFm. Finally, the equilibrium constant of binding (Kd) to DNA of recombinant rat mTERFm was estimated to be approximately10 nM.
###end p 41
###begin p 42
###xml 64 70 64 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 176 178 176 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 341 342 341 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh528f2">2</xref>
###xml 405 406 405 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 406 407 406 407 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 14 17 <span type="species:ncbi:10116">rat</span>
###xml 64 70 <span type="species:ncbi:562">E.coli</span>
A full-length rat mTERF for the mature protein was expressed in E.coli as a histidine N-terminal tagged fusion protein and this recombinant his-mTERF protein was purified by Ni2+ affinity chromatography (data not shown). In order to analyze the his-mTERF functional capacity, the DNA-binding activity was determined by gel shift assay (Fig. 2C) and the equilibrium binding constant calculated. A value of Kd approximately240 nM was obtained.
###end p 42
###begin p 43
###xml 248 249 248 249 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 288 289 288 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh528f3">3</xref>
###xml 638 639 614 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh528f3">3</xref>
###xml 734 735 698 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh528f3">3</xref>
###xml 1007 1008 971 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh528f4">4</xref>
###xml 1451 1452 1415 1416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh528f4">4</xref>
###xml 1639 1640 1603 1604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh528f4">4</xref>
###xml 1935 1936 1899 1900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh528f4">4</xref>
###xml 1985 1991 1949 1955 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 40 43 <span type="species:ncbi:10116">rat</span>
###xml 100 105 <span type="species:ncbi:9606">human</span>
###xml 222 227 <span type="species:ncbi:9606">human</span>
###xml 259 262 <span type="species:ncbi:10116">rat</span>
###xml 504 507 <span type="species:ncbi:10116">rat</span>
###xml 778 781 <span type="species:ncbi:10116">rat</span>
###xml 917 920 <span type="species:ncbi:10116">rat</span>
###xml 1160 1163 <span type="species:ncbi:10116">rat</span>
###xml 1323 1326 <span type="species:ncbi:10116">rat</span>
###xml 1962 1965 <span type="species:ncbi:10116">rat</span>
###xml 1985 1991 <span type="species:ncbi:562">E.coli</span>
Termination activity of the recombinant rat mTERFm and his-mTERF proteins was characterized using a human mtS100 lysate as a source of mtRNA polymerase activity and using a chimeric template (pGHLT plasmid) containing the human L-strand promoter (IL) and the rat mTERF binding site (Fig. 3A). The recombinant proteins were able to support transcription termination activity when added to the system, producing a transcript of approximately188 nt which was not present in the absence of the protein. When rat mTERFm was present in the reaction, a high percentage (approximately65%) of transcripts was stopped at the termination site (Fig. 3B), while only approximately10% of termination was produced in the presence of his-mTERF (Fig. 3C). In order to investigate the ability of rat mTERF to interfere with RNA chain elongation catalyzed by bacteriophage RNA polymerases, another template (pGTER plasmid) carrying the rat mTERF binding site in either orientation relative to the bacteriophage promoter (Fig. 4A) was linearized downstream of the selected promoter and then transcribed with the proper bacteriophage RNA polymerase, in the absence and presence of rat mTERF. When the termination activity was tested with SP6 RNA polymerase and pGTER(NcoI) template, two classes of transcripts were generated in the presence of rat mTERFm: a longer run-off transcript and a shorter truncated transcript which corresponds to transcription termination (Fig. 4B). With a protein concentration of 2.6 nM a 50% level of termination was obtained. Transcription with T7 RNA polymerase and pGTER(SalI) template yielded a 40% level of termination (Fig. 4C). Finally, transcription with bacteriophage RNA polymerase generated terminated transcripts in the presence of his-mTERF when the termination site was placed either in the forward orientation with respect to the SP6 promoter or in the reverse orientation with respect to the T7 promoter (Fig. 4D). Thus, the recombinant rat mTERF expressed in E.coli is able to bind to the termination site and produce termination of transcription.
###end p 43
###begin title 44
###xml 0 3 <span type="species:ncbi:10116">Rat</span>
Rat mTERF is phosphorylated at multiple sites
###end title 44
###begin p 45
###xml 244 246 244 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 323 324 323 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh528f5">5</xref>
###xml 785 786 785 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh528f5">5</xref>
###xml 980 981 980 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh528f5">5</xref>
###xml 1504 1505 1504 1505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh528f5">5</xref>
###xml 16 19 <span type="species:ncbi:10116">rat</span>
###xml 267 270 <span type="species:ncbi:10116">rat</span>
###xml 937 942 <span type="species:ncbi:9606">human</span>
###xml 1048 1051 <span type="species:ncbi:10116">rat</span>
###xml 1153 1156 <span type="species:ncbi:10116">rat</span>
###xml 1634 1637 <span type="species:ncbi:10116">rat</span>
The activity of rat mTERF could be regulated by post-transcriptional modification, and phosphorylation is one of the major mechanisms for regulating protein function in eukaryotic cells. As a first step to address this issue, the migration of [35S]methionine-labeled rat mTERFm was analyzed by 2D gel electrophoresis (Fig. 5A). In the first dimension (isoelectrofocusing), the proteins were separated by charge, whereas in the second dimension (SDS-PAGE) the proteins were separated by size. On 2D gels, two populations were observed with different pI values. After treatment with CIAP, only the population of the unmodified protein with a theoretical pI of 9.2 remained. The other population, with a calculated pI of 8.28, corresponded to the protein with four phosphate groups (Fig. 5A, right panel). Another similar experiment carried out with h-mtS100 lysate and revealed with a polyclonal antibody anti-mTERF indicated that natural human mTERF also has four phosphates (Fig. 5B). Taken together, these results provide convincing evidence that rat mTERF is susceptible to being phosphorylated on four amino acid residues. In order to investigate if rat his-mTERF was also phosphorylated, the protein was expressed in bacteria, purified and resolved by SDS-PAGE and the phosphoamino acid content was determined by immunoblot analysis. For this purpose antibodies specifically detecting phosphotyrosine (anti-P-Y), phosphoserine (anti-P-S) and phosphothreonine (anti-P-T) were used. As shown in Figure 5C, the three antibodies recognize a protein with an apparent molecular mass of 40 kDa that represents the phosphorylated form of rat his-mTERF.
###end p 45
###begin title 46
Inhibition of transcription termination activity by dephosphorylation of his-mTERF
###end title 46
###begin p 47
###xml 236 237 236 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh528f6">6</xref>
###xml 1203 1205 1203 1205 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 1253 1254 1253 1254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh528f6">6</xref>
###xml 1786 1787 1786 1787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh528f7">7</xref>
###xml 1931 1932 1931 1932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh528f6">6</xref>
###xml 1943 1944 1943 1944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh528f6">6</xref>
###xml 93 96 <span type="species:ncbi:10116">rat</span>
###xml 1072 1075 <span type="species:ncbi:10116">rat</span>
###xml 1716 1719 <span type="species:ncbi:10116">rat</span>
###xml 1913 1918 <span type="species:ncbi:9606">human</span>
###xml 2033 2038 <span type="species:ncbi:9606">human</span>
As a first step to find out whether phosphorylation may regulate mTERF termination activity, rat his-mTERF expressed in bacteria and then purified was treated with agarose-coupled CIAP and used in transcription termination assays (Fig. 6A). When untreated protein was added to the assay (lane 2), a clear termination band appeared, which was not present in the absence of the protein (lane 1). Most significantly, CIAP treatment produced a total inhibition of his-mTERF transcription termination activity (lane 3) and no termination band was present. This inhibitory effect was produced by dephosphorylation and not by the interference effect of agarose (lane 4). A low abundance RNA species shorter than the run-off transcripts was present regardless of the presence of mTERF and this was probably the result of either degradation of the run-off transcripts or mTERF-independent pausing or termination. The reduced overall transcription observed in lanes 2-4 seems to be due to an inhibition of T7 RNA polymerase by his-mTERF. To test whether the DNA-binding activity of rat his-mTERF is also controlled by phosphorylation, recombinant and CIAP-treated protein was subjected to band shift assays using 32P-labeled termination probe. As shown in Figure 6B, the protein produced a single retarded band (lane2), which remained unaffected after dephosphorylation (lane 4 versus lane 3). The reduction in transcription termination activity (lane 4) and the lower signal of retarded bands in lanes 3 and 4 with respect to the control (lanes 2) were due to the partial loss of protein after agarose treatment. These results provide direct evidence that dephosphorylation inhibits the transcription termination activity of rat mTERF, but that it does not affect its DNA-binding capacity (Fig. 7). More conclusive evidence concerning termination activity regulation by phosphorylation was obtained using purified natural human mTERF (Fig. 6C). Figure 6C shows the results of termination assays carried out with equivalent amounts of natural human mTERF proteins, both CIAP-treated and untreated. It is clear that the CIAP-treated protein almost completely lacks transcription termination-promoting activity, the remaining termination activity being due to endogenous mTERF present in h-mtS100.
###end p 47
###begin title 48
DISCUSSION
###end title 48
###begin p 49
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c10">10</xref>
###xml 384 393 384 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P.lividus</italic>
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c17">17</xref>
###xml 403 432 403 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Strongylocentrotus purpuratus</italic>
###xml 434 436 434 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c20">20</xref>
###xml 27 30 <span type="species:ncbi:10116">rat</span>
###xml 95 100 <span type="species:ncbi:9606">human</span>
###xml 233 238 <span type="species:ncbi:10090">mouse</span>
###xml 243 246 <span type="species:ncbi:9823">pig</span>
###xml 384 393 <span type="species:ncbi:7656">P.lividus</span>
###xml 403 432 <span type="species:ncbi:7668">Strongylocentrotus purpuratus</span>
The amino acid sequence of rat mTERF conserved the modular organization previously observed in human mTERF (10), with two widely separated basic regions and three leucine zipper motifs; the same organization is also conserved in the mouse and pig orthologs. This feature supports the hypothesis that the four proteins share the same 3-dimensional structure. mtDBP from the sea urchin P.lividus (17) and Strongylocentrotus purpuratus (20) also presents a modular organization with two leucine zipper motifs and two DNA-binding domains.
###end p 49
###begin p 50
###xml 41 49 41 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 186 187 186 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 187 188 187 188 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c10">10</xref>
###xml 648 650 648 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c17">17</xref>
###xml 51 54 <span type="species:ncbi:10116">rat</span>
###xml 333 336 <span type="species:ncbi:10116">rat</span>
###xml 620 625 <span type="species:ncbi:9606">human</span>
The recombinant mature protein expressed in vitro (rat mTERFm) or expressed in a bacterial system (his-mTERF) conserves the specific DNA-binding capacity to the termination region, with Kd values of 10 and 240 nM, respectively. This difference could be due to the presence of a large percentage of inactive or misfolded molecules of rat his-mTERF from bacterial expression or to possible differences of post-translational modification between the two expression systems. It could also be an effect of the polyhistidine tag on the N-terminus of his-mTERF, because the importance of this region in the binding activity of human mTERF (10) and mtDBP (17) has been demonstrated.
###end p 50
###begin p 51
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c10">10</xref>
###xml 439 441 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c10">10</xref>
###xml 495 501 495 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 121 124 <span type="species:ncbi:10116">rat</span>
###xml 214 219 <span type="species:ncbi:9606">human</span>
###xml 302 307 <span type="species:ncbi:9606">human</span>
###xml 459 462 <span type="species:ncbi:10116">rat</span>
###xml 495 501 <span type="species:ncbi:562">E.coli</span>
The most important point concerning termination-promoting activity was the capacity of both recombinant mature proteins (rat mTERFm and his-mTERF) to support transcription termination, differently from recombinant human mTERF, which lacks termination activity (10). The lack of termination activity of human mTERF was explained by the absence of a secondary modification of the primary translation product or another additional factor(s) (10). In the case of rat mTERF, the protein expressed in E.coli and purified (his-mTERF) was active for mitochondrial transcription termination. This observation rules out the need for an additional factor(s) and points to a secondary modification being required for termination activity.
###end p 51
###begin p 52
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c21">21</xref>
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c22">22</xref>
###xml 29 32 <span type="species:ncbi:10116">rat</span>
###xml 93 98 <span type="species:ncbi:9606">human</span>
###xml 185 190 <span type="species:ncbi:9606">human</span>
###xml 229 232 <span type="species:ncbi:10116">rat</span>
###xml 245 250 <span type="species:ncbi:9606">human</span>
Furthermore, the recombinant rat mTERF was able to terminate transcription when initiated by human mtRNA polymerase, SP6 or T7 RNA polymerase. This behavior is similar to that shown by human mTERF (21) and mtDBP (22). Therefore, rat mTERF, like human mTERF and mtDBP, is not RNA polymerase-specific.
###end p 52
###begin p 53
###xml 111 117 111 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh528f5">5</xref>
###xml 27 30 <span type="species:ncbi:10116">rat</span>
###xml 53 59 <span type="species:ncbi:9986">rabbit</span>
###xml 84 87 <span type="species:ncbi:10116">rat</span>
###xml 111 117 <span type="species:ncbi:562">E.coli</span>
Both recombinant proteins, rat mTERFm synthesized in rabbit reticulocyte lysate and rat his-mTERF expressed in E.coli, are phosphorylated (Fig. 5A and C). The origin of the phosphorylation in these two different systems, one prokaryotic and the other eukaryotic, is presently under investigation in our laboratory.
###end p 53
###begin p 54
###xml 720 722 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c23">23</xref>
###xml 723 725 723 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c24">24</xref>
###xml 964 965 964 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh528f6">6</xref>
###xml 1460 1461 1460 1461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c9">9</xref>
###xml 1651 1653 1651 1653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c10">10</xref>
###xml 2019 2021 2019 2021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c25">25</xref>
###xml 2077 2079 2077 2079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c26">26</xref>
###xml 2375 2377 2375 2377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c27">27</xref>
###xml 2683 2685 2683 2685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c28">28</xref>
###xml 118 121 <span type="species:ncbi:10116">rat</span>
###xml 214 217 <span type="species:ncbi:10116">Rat</span>
###xml 415 420 <span type="species:ncbi:9606">human</span>
###xml 745 748 <span type="species:ncbi:10116">rat</span>
###xml 767 772 <span type="species:ncbi:9606">human</span>
###xml 1391 1396 <span type="species:ncbi:9606">human</span>
###xml 1638 1643 <span type="species:ncbi:9606">human</span>
###xml 1964 1969 <span type="species:ncbi:4932">yeast</span>
###xml 2027 2032 <span type="species:ncbi:10090">mouse</span>
###xml 2409 2414 <span type="species:ncbi:9606">human</span>
The most important result presented in this study is the demonstration that the transcription termination activity of rat mTERF is regulated by phosphorylation while the DNA-binding activity of the protein is not. Rat mTERFm resolved into two clear bands in a 2D gel, with the band of lower pI being a phosphorylated form of the protein with four phosphate groups. The data also provide novel evidence that natural human mTERF is mostly phosphorylated at four sites, although the phosphorylation is more heterogeneous. This observation indicates that mTERF is phosphorylated physiologically by mitochondrial kinases. Evidence for mitochondrial protein phosphorylation in various cell types has been previously reported (23,24). Both recombinant rat mTERF and natural human mTERF are active in promoting transcription termination and both are phosphorylated. Furthermore, the non-phosphorylated forms of mTERFs were transcriptionally inactive for termination (Fig. 6A and C). These results demonstrate that the termination activity of mTERF is regulated by phosphorylation and suggest that phosphorylation/dephosphorylation may be an important physiological regulatory mechanism for the activity of this protein. However, whereas transcription termination activity is inhibited by dephosphorylation, the DNA-binding activity of mTERF remains unaffected. Furthermore, phosphatase treatment of human mTERF does not affect the DNA-binding activity of the protein (9). Therefore, both activities are separable and the binding of mTERF to DNA is necessary but not sufficient to terminate transcription, as was previously shown with recombinant human mTERF (10). Phos phorylation is, by any criterion, the most widely used regulatory mechanism for modulating enzyme activity in eukaryotic cells. There are countless examples in which the reversible addition of a phosphate moiety serves as a key switch to activate or inactivate enzyme activity. Thus, phosphorylation of yeast mitochondrial transcription factor A (Sc-mtTFA) (25) and mouse transcription termination factor I (TTF-1) (26) regulates binding of the protein to DNA. Moreover, the protein RNA polymerase I and transcript release factor (PTRF), which interacts with RNA polymerase I, TTF-1 and the 3'-end of pre-rRNA, is phosphorylated at multiple sites and fractionates into transcriptionally active and inactive forms (27). Likewise, the phosphorylated human La antigen (a RNA-binding protein that facilitates transcriptional termination and reinitiation by RNA polymerase III) binds RNA efficiently but does not support efficient transcription and the phosphoprotein can be reactivated for transcription by dephosphorylation (28).
###end p 54
###begin p 55
###xml 150 151 150 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh528f7">7</xref>
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c29">29</xref>
Therefore, mTERF is the first protein having a role in mammalian mitochondrial gene expression that appears to be controlled by phosphorylation (Fig. 7). Furthermore, mTERF phosphorylation may modulate the mitochondrial synthesis ratio mRNA:rRNA in response to intra-mitochondrial signals (29).
###end p 55
###begin p 56
###xml 80 82 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c30">30</xref>
Recently, a new model of mTERF regulation by oligomerization has been proposed (30). In this model, the activity of the protein is modulated by the transition between an active monomer and an inactive trimer, which has no DNA-binding activity.
###end p 56
###begin title 57
Figures and Tables
###end title 57
###begin p 58
###xml 221 238 221 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rattus norvegicus</italic>
###xml 248 260 248 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus</italic>
###xml 270 282 270 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Homo sapiens</italic>
###xml 293 303 293 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sus scrofa</italic>
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh528c31">31</xref>
###xml 216 219 <span type="species:ncbi:10116">rat</span>
###xml 221 238 <span type="species:ncbi:10116">Rattus norvegicus</span>
###xml 241 246 <span type="species:ncbi:10090">mouse</span>
###xml 248 260 <span type="species:ncbi:10090">Mus musculus</span>
###xml 263 268 <span type="species:ncbi:9606">human</span>
###xml 270 282 <span type="species:ncbi:9606">Homo sapiens</span>
###xml 288 291 <span type="species:ncbi:9823">pig</span>
###xml 293 303 <span type="species:ncbi:9823">Sus scrofa</span>
 Sequence alignment of mTERFs. The presequence of 37 amino acids is shown by dotted line. The position of leucine zippers (Lz) and the two basic regions (B1 and B2) are shown. Alignment of the amino acid sequence of rat (Rattus norvegicus), mouse (Mus musculus), human (Homo sapiens) and pig (Sus scrofa) mTERF is shown. Asterisks indicate identical amino acids; colons and dots indicate very similar residues (31).
###end p 58
###begin p 59
###xml 38 39 38 39 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 253 261 247 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 528 536 516 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 561 562 549 550 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 600 601 588 589 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 607 609 595 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 688 689 676 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 689 690 677 678 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 26 29 <span type="species:ncbi:10116">rat</span>
###xml 53 56 <span type="species:ncbi:10116">rat</span>
###xml 94 97 <span type="species:ncbi:10116">rat</span>
###xml 289 292 <span type="species:ncbi:10116">rat</span>
###xml 330 333 <span type="species:ncbi:10116">rat</span>
###xml 362 365 <span type="species:ncbi:10116">rat</span>
###xml 549 552 <span type="species:ncbi:10116">rat</span>
 Functional properties of rat mTERF. (A) Analysis of rat mTERF after incubation with isolated rat mitochondria for 1 h at 37degreesC under various conditions (lanes 1-4). ATP (lanes 2-4), trypsin (lanes 3 and 4) and Triton X-100 (lane 4) were used. The in vitro synthesized mature protein rat mTERFm is shown in lane 5. Import of rat mTERF after incubation with rat mitochondria for 30 min at 37degreesC in the presence (lane 7) or absence (lane 6) of the uncoupler CCCP. p, precursor; m, mature. Mobility shift assay using the in vitro synthesized rat mTERFm (B) or his-mTERF expressed in bacteria (C) and 32P-labeled termination probe. Lineweaver-Burk plot analysis was used to measure Kd (right panels). C, protein-DNA complex; F, free probe.
###end p 59
###begin p 60
###xml 51 52 51 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 191 192 191 192 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 208 209 208 209 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 39 42 <span type="species:ncbi:10116">rat</span>
###xml 179 182 <span type="species:ncbi:10116">rat</span>
###xml 236 241 <span type="species:ncbi:9606">human</span>
 Transcription termination activity of rat mTERF. (A) Schematic diagram of pGHLT template used in transcription termination assays is shown. Transcription termination activity of rat mTERFm (B) or his-mTERF (C) when it was initiated by human mitochondrial RNA polymerase (h-mtS100). R, run-off transcripts; T, terminated transcripts; %T, percentage of termination activity.
###end p 60
###begin p 61
###xml 51 52 51 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 194 195 194 195 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 219 220 219 220 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 224 225 224 225 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 39 42 <span type="species:ncbi:10116">rat</span>
###xml 138 141 <span type="species:ncbi:10116">rat</span>
###xml 265 268 <span type="species:ncbi:10116">rat</span>
 Transcription termination activity of rat mTERF. (A) Schematic diagram of pGTER template is shown. Transcription termination activity of rat mTERFm when it was initiated by SP6 RNA polymerase (B) or T7 RNA polymerase (C). (D) Transcription termination activity of rat his-mTERF when the transcription was initiated by SP6 (first three lanes) or T7 RNA polymerase (last three lanes). R, run-off transcripts; T, terminated transcripts; M, markers (MspI-digested plasmid pBR322); %T, percentage of termination activity.
###end p 61
###begin p 62
###xml 45 46 45 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 92 100 92 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 118 120 118 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 199 200 199 200 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 620 621 596 597 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 141 144 <span type="species:ncbi:10116">rat</span>
###xml 246 251 <span type="species:ncbi:9606">human</span>
###xml 267 272 <span type="species:ncbi:9606">human</span>
###xml 401 404 <span type="species:ncbi:10116">rat</span>
###xml 437 442 <span type="species:ncbi:9606">human</span>
###xml 534 537 <span type="species:ncbi:10116">rat</span>
###xml 549 554 <span type="species:ncbi:9606">human</span>
###xml 659 662 <span type="species:ncbi:10116">rat</span>
 mTERF is phosphorylated at multiple sites. (A) Two-dimensional gel electrophoresis (2D) of in vitro synthesized and [35S]methionine-labeled rat mTERFm before (-) and after (+) treatment with CIAP. (B) Another similar experiment carried out with human mtS100 lysate (human mTERF) and revealed with a polyclonal antibody anti-mTERF. Both methods showed a phosphorylated spot at pI approximately8.2 for rat mTERFm and approximately9.2 for human mTERF, which correspond to four phosphorylated residues (right panel). The left sides show rat mTERFm and human mTERF when they were running in a well in parallel in SDS-PAGE. (C) The bacteria expressed and purified rat his-mTERF was revealed using antibodies against phosphotyrosine (anti P-Y), phosphoserine (anti P-S) and phosphothreonine (anti P-T). CB was stained with Coomassie blue.
###end p 62
###begin p 63
###xml 156 157 156 157 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 236 237 236 237 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 408 409 408 409 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 758 763 <span type="species:ncbi:9606">human</span>
 Phosphatase treatment abolishes transcription termination activity. Recombinant his-mTERF protein (120 nM) was treated with agarose-coupled CIAP and then (A) used in a transcription termination assay initiated by T7 RNA polymerase or (B) DNA binding assay with termination probe. Lane 1, no his-mTERF protein added; lane 2, untreated protein; lane 3, CIAP-treated protein; lane 4, agarose-treated protein. (C) Schematic diagram of the template (pTER) and probe used in the transcription termination assays and S1 protection analysis. Only the upstream initiation site for H-strand transcription is shown in the pTER map. The picture shows the S1 protection products from assays of transcription termination activity using CIAP-treated or untreated purified human mTERF. R, run-off transcripts; T, terminated transcripts; %T, percentage of termination activity; C, protein-DNA complex; F, free probe.
###end p 63
###begin p 64
 Proposed model of mTERF regulation by phosphorylation. In the dephosphorylated state, the HSP-initiated transcripts proceeded to the full length of the mtDNA. The phosphorylation of mTERF may cause structural remodeling of the DNA-protein complex, causing an increase in termination activity. The circles labeled P represent phosphorylated residues.
###end p 64
###begin title 65
ACKNOWLEDGEMENTS
###end title 65
###begin p 66
###xml 177 182 <span type="species:ncbi:9606">human</span>
We would like to thank Alicia Torrado, Patricio Fernandez-Silva and Miguel A. Fernandez-Moreno for valuable comments on the manuscript and Giuseppe Attardi for the kind gift of human mTERF antibodies. The help of Patricia Perez-Galan and Maria A. Alava in western blot experiments is gratefully acknowledged. This work was supported by a grant from the Spanish Ministerio de Ciencia y Tecnologia (BMC 2001-2421).
###end p 66
###begin title 67
REFERENCES
###end title 67

